GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NuCana PLC (NAS:NCNA) » Definitions » Selling and Marketing Expense

NuCana (NuCana) Selling and Marketing Expense : $0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is NuCana Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. NuCana's Selling and Marketing Expense for the three months ended in Mar. 2024 was $0.00 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 was $0.00 Mil.


NuCana Selling and Marketing Expense Historical Data

The historical data trend for NuCana's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuCana Selling and Marketing Expense Chart

NuCana Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only - - - - -

NuCana Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NuCana Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NuCana Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of NuCana's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


NuCana (NuCana) Business Description

Industry
Traded in Other Exchanges
Address
3 Lochside Way, Edinburgh, GBR, EH12 9DT
NuCana PLC is a biopharmaceutical company focused on improving treatment outcome for cancer patients by ProTide technology. Utilising proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. Geographically operates through the region of the United States.

NuCana (NuCana) Headlines

From GuruFocus

NuCana to Participate in the 2022 Jefferies Healthcare Conference

By GuruFocusNews GuruFocusNews 06-21-2022

NuCana to Host Investor Meetings During the J.P. Morgan Healthcare Conference

By Stock market mentor Stock market mentor 01-03-2023

NuCana to Present at the Jefferies London Healthcare Conference

By Value_Insider Value_Insider 11-08-2022

NuCana Announces Receipt of NASDAQ Notice

By GuruFocusNews GuruFocusNews 06-23-2022

NuCana to Present at the Jefferies Healthcare Conference

By sperokesalga sperokesalga 06-01-2023

NuCana Announces Receipt of NASDAQ Notice

By GuruFocusNews GuruFocusNews 07-03-2022